A computational tool (H-MAGMA) for improved prediction of brain-disorder risk genes by incorporating brain chromatin interaction profiles.
Nancy Y A SeyBenxia HuWon MahHarper FauniJessica Caitlin McAfeePrashanth RajarajanKristen J BrennandSchahram AkbarianHyejung WonPublished in: Nature neuroscience (2020)
Most risk variants for brain disorders identified by genome-wide association studies reside in the noncoding genome, which makes deciphering biological mechanisms difficult. A commonly used tool, multimarker analysis of genomic annotation (MAGMA), addresses this issue by aggregating single nucleotide polymorphism associations to nearest genes. Here we developed a platform, Hi-C-coupled MAGMA (H-MAGMA), that advances MAGMA by incorporating chromatin interaction profiles from human brain tissue across two developmental epochs and two brain cell types. By analyzing gene regulatory relationships in the disease-relevant tissue, H-MAGMA identified neurobiologically relevant target genes. We applied H-MAGMA to five psychiatric disorders and four neurodegenerative disorders to interrogate biological pathways, developmental windows and cell types implicated for each disorder. Psychiatric-disorder risk genes tended to be expressed during mid-gestation and in excitatory neurons, whereas neurodegenerative-disorder risk genes showed increasing expression over time and more diverse cell-type specificities. H-MAGMA adds to existing analytic frameworks to help identify the neurobiological principles of brain disorders.
Keyphrases
- genome wide
- resting state
- white matter
- genome wide identification
- gene expression
- functional connectivity
- dna methylation
- bioinformatics analysis
- transcription factor
- cell therapy
- single cell
- poor prognosis
- mental health
- stem cells
- high throughput
- spinal cord injury
- multiple sclerosis
- genome wide analysis
- bone marrow
- brain injury